A Randomized Phase 2 Study of Paclitaxel and Carboplatin With or Without Conatumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer
Academic Article
Publication Date:
2013
Short description:
A Randomized Phase 2 Study of Paclitaxel and Carboplatin With or Without Conatumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer / Paz Ares, A., Bálint, B., de Boer, R.h., van Meerbeeck, J.p., Wierzbicki, R., De Souza, P., Galimi, F., Haddad, V., Sabin, T., Hei, Y., Pan, Y., Cottrell, S., Hsu, C.p., Ramlau, R.. - In: JOURNAL OF THORACIC ONCOLOGY. - ISSN 1556-0864. - 8:3(2013), pp. 329-337. [10.1097/JTO.0b013e31827ce554]
Iris type:
1.1 Articolo in rivista
List of contributors:
Paz Ares, A; Bálint, B; de Boer, Rh; van Meerbeeck, Jp; Wierzbicki, R; De Souza, P; Galimi, Francesco; Haddad, V; Sabin, T; Hei, Y; Pan, Y; Cottrell, S; Hsu, Cp; Ramlau, R.
Published in: